Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM6B | O15054 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 7/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 6/20 | 0.58 |
| ▸ | RECQL | P46063 | 6/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.58 |
| ▸ | USP2 | O75604 | 4/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.58 |
| ▸ | FYN | P06241 | 3/20 | 0.58 |
| ▸ | LCK | P06239 | 3/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.58 |
| ▸ | HTR2A | P28223 | 2/20 | 0.58 |
| ▸ | EGFR | P00533 | 2/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 6/20 | 0.53 |
| ▸ | MAPT | P10636 | 6/20 | 0.53 |
| ▸ | POLB | P06746 | 5/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 4/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29794141 | 1.00 | KDM6B (0.60) | KDM6BKDM4EHSD17B10TDP1ALOX15 | |
| SCHEMBL29913698 | 0.85 | KDM6B (0.62) | KDM6BKDM4EHSD17B10TDP1ALOX15 | |
| SCHEMBL11664157 | 0.84 | KDM4E (0.59) | KDM6BKDM4EHSD17B10TDP1ALOX15 | |
| SCHEMBL30130608 | 0.83 | KDM6B (0.60) | KDM6BKDM4EHSD17B10TDP1ALOX15 | |
| SCHEMBL31746120 | 0.83 | KDM4E (0.63) | KDM6BKDM4EHSD17B10TDP1ALOX15 | |
| SCHEMBL29504521 | 0.83 | KDM6B (0.55) | KDM6BKDM4EHSD17B10TDP1ALOX15 | |
| SCHEMBL12608303 | 0.81 | KDM6B (0.50) | KDM6BKDM4EHSD17B10TDP1ALOX15 | |
| SCHEMBL38225 | 0.81 | SLC7A5 (0.55) | SLC7A5MAPTALDH1A1ESR1SLC6A2 | |
| SCHEMBL21899391 | 0.81 | SLC7A5 (0.55) | SLC7A5MAPTALDH1A1ESR1SLC6A2 | |
| SCHEMBL38224 | 0.81 | SLC7A5 (0.55) | SLC7A5MAPTALDH1A1ESR1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180193209-A1 | A POLYMER PRODUCT AND PREPARATION THEROF | SINGAPORE HEALTH SERVICES PTE LTD. (SG) | 2018-07-12 | — | — | US | claimed |
| EP-3319779-A1 | A POLYMER PRODUCT AND PREPARATION THEREOF | Singapore Health Services Pte Ltd (SG) | 2018-05-16 | — | — | EP | claimed |
| EP-4731266-A1 | NANOPARTICLE COMPOSITIONS ASSOCIATED WITH PEPTIDES | The Regents of the University of Michigan (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20260108618-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS | CIDARA THERAPEUTICS, INC. | 2026-04-23 | — | — | US | disclosed |
| US-12569565-B2 | Compositions and methods for the treatment of viral infections | CIDARA THERAPEUTICS, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| US-20260000781-A1 | FC CONJUGATES INCLUDING AN INHIBITOR OF CD73 AND USES THEREOF | CIDARA THERAPEUTICS INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-20250325644-A1 | ALK POLYPEPTIDES AND METHODS OF USE THEREOF | ELICIO THERAPEUTICS INC (US) | 2025-10-23 | — | — | US | disclosed |
| EP-4627079-A2 | THERMOSTABLE BINDING SCAFFOLDS | Nectagen, Inc. (US) | 2025-10-08 | — | — | EP | disclosed |
| US-12427200-B2 | Compositions and methods for the treatment of viral infections | CIDARA THERAPEUTICS, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| US-12370245-B2 | ALK polypeptides and methods of use thereof | Elicio Therapeutics, Inc. (US) | 2025-07-29 | — | — | US | disclosed |
| US-20250177503-A1 | COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISORDERS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2025-06-05 | — | — | US | disclosed |
| WO-2008098280-A1 | METHODS FOR THE SYNTHESIS OF DICARBA BRIDGES IN GROWTH HORMONE PEPTIDES | POLYCHIP PHARMACEUTICALS PTY LTD (AU) | 2008-08-21 | — | — | WO | disclosed |
| WO-2008077194-A1 | RECEPTOR AGONISTS | XENOME LTD (AU) | 2008-07-03 | — | — | WO | disclosed |
| US-7312195-B2 | Cyclised conotoxin peptides | THE UNIVERSITY OF QUEENSLAND (AU) | 2007-12-25 | — | — | US | disclosed |
| WO-2007118270-A1 | CYCLISED ALPHA-CONOTOXIN PEPTIDES | THE UNIVERSITY OF QUEENSLAND (AU) | 2007-10-25 | — | — | WO | disclosed |
| US-20060270832-A1 | Novel x-conotoxin peptides (-II) | XENOME LIMITED (AU) | 2006-11-30 | — | — | US | disclosed |
| US-20050256301-A1 | Cyclised conotoxin peptides | THE UNIVERSITY OF QUEENSLAND (AU) | 2005-11-17 | — | — | US | disclosed |
| EP-1578787-A1 | NOVEL CHI-CONOTOXIN PEPTIDES (-II) | Xenome Ltd (AU) | 2005-09-28 | — | — | EP | disclosed |
| WO-2004099238-A1 | NOVEL mu-CONOTOXIN PEPTIDES | THE UNIVERSITY OF QUEENSLAND (AU) | 2004-11-18 | — | — | WO | disclosed |
| WO-2004050688-A1 | NOVEL χ-CONOTOXIN PEPTIDES (-II) | XENOME LTD (AU) | 2004-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12427200-B2 | Compositions and methods for the treatment of viral infections | FCGR3B, ALB, FCGR1A | KDM6B 4446/4885KDM4E 4753/4885HSD17B10 4645/4885 |
| US-20050256301-A1 | Cyclised conotoxin peptides | VIP, CANX, IAPP | KDM6B 4504/4885KDM4E 4489/4885HSD17B10 2676/4885 |
| US-20260108618-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS | FCGR3B, FCGR1A, FCGR2A | KDM6B 539/4885KDM4E 1225/4885HSD17B10 4780/4885 |
| US-12569565-B2 | Compositions and methods for the treatment of viral infections | ALB, FCGR3B, FCGR1A | KDM6B 1093/4885KDM4E 1470/4885HSD17B10 4784/4885 |
| US-20260000781-A1 | FC CONJUGATES INCLUDING AN INHIBITOR OF CD73 AND USES THEREOF | FCGR2A, FCGR1A, FCGR3B | KDM6B 1249/4885KDM4E 1204/4885HSD17B10 2909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.